c/compounding · created 9 Oct 2023
503A/503B, shortage rules, telehealth pharmacies and what changed this quarter.
503A vs 503B in one paragraph, because everyone conflates them — a position I have arrived at slowly and would like tested. Asked for the beyond-use date basis and got…
The title is the argument: compounded tirz pricing in my state, six months of receipts. Here is the rest of it. A 503A pharmacy compounds for an identified patient…
asked my compounder where the API comes from. long silence. Not a hot take, just something I have not seen said plainly here. Compounded preparations are not approved…
why "compounded" does not mean "generic". If you already knew this, the post is not for you and you can scroll on. Asked which facility and got a name straight away.…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsthe shortage list came off and my pharmacy stopped overnight. It is the sort of thing everyone half-believes and nobody writes down. Kept the label from every vial.…
Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference